TJP1 and dengue disease: Rupatadine significantly inhibited the effects of dengue sera on human endothelial cells lines by reducing the reduction in trans-endothelial resistance and a reduction is ZO-1 expression and also showed small but significant differences in the extent of fluid leakage and thrombocytopenia, when the drug was given early [3].